The derailment of a promising hepatitis C treatment show how sometimes drugs can die not because they don't work, but because they don't make business sense.
WSJ.com: What's News US, Wall Street Journal
Wed, 11/14/2012 - 5:33pm
The derailment of a promising hepatitis C treatment show how sometimes drugs can die not because they don't work, but because they don't make business sense.